ALL announcements

Actylis Announces Exclusive Distribution Partnership with Aarti Industries Limited for PCBTF Solvent
February 9, 2026

Actylis Announces Exclusive Distribution Partnership with Aarti Industries Limited for PCBTF Solvent

Actylis has entered into an exclusive distribution partnership in North America with Aarti Industries Limited

See More Arrow pointing right
Expansion of distribution partnership in the US Actylis and Novo Nordisk Pharmatech are expanding their strategic partnership for the distribution of Benzalkonium Chloride in the United States of America
April 28, 2026

Expansion of distribution partnership in the US

Actylis and Novo Nordisk Pharmatech are expanding their strategic partnership

Expansion of distribution partnership in the US Actylis and Novo Nordisk Pharmatech are expanding their strategic partnership for the distribution of Benzalkonium Chloride in the United States of America.

See More Arrow pointing right
Actylis announces a strategic distribution partnership with Emissary to expand its presence in the personal care market in France and Switzerland.
October 23, 2025

Actylis announces a strategic distribution partnership with Emissary

Expansion of personal care market in France and Switzerland.

Actylis announces a strategic distribution partnership with Emissary to expand its presence in the personal care market in France and Switzerland.

See More Arrow pointing right
Actylis Acquires Pharm-Rx
March 3, 2025

Actylis Acquires Pharm-Rx

Strengthening Our Commitment to Innovation and Customer Success in VMS and Pharma

We are delighted to announce the strategic acquisition of Pharm-Rx. This acquisition significantly enhances our ability to deliver exceptional value to our customers, increase our range of solutions for clients, and strengthen our strategic supplier partnerships to enhance our innovative portfolio and service offerings. Pharm-Rx’s strong team and industry expertise broadens our capabilities to help accelerate growth with nutrition and over-the-counter (OTC) pharmaceutical customers.

See More Arrow pointing right
Actylis and Novo Nordisk Pharmatech are Expanding their Strategic Partnership for the Distribution of Benzalkonium Chloride in Targeted European Countries.
January 20, 2025

Expansion of distribution partnership in Europe

Actylis and Novo Nordisk Pharmatech are expanding their strategic partnership

Actylis and Novo Nordisk Pharmatech are expanding their strategic partnership for the distribution of Benzalkonium Chloride in targeted European countries.

See More Arrow pointing right
Actylis Achieves Gold EcoVadis Rating, Demonstrating Commitment to Sustainability Excellence
January 1, 2025

Actylis Achieves Gold top 5% EcoVadis Rating

Actylis Achieves Gold EcoVadis Rating, Demonstrating Commitment to Sustainability Excellence

Actylis is proud to announce its attainment of a Gold rating from EcoVadis, solidifying its position in the top 5 percentile among industry peers. This remarkable achievement underscores Actylis' unwavering commitment to sustainable practices and its dedication to fostering a more responsible and eco-conscious future.

See More Arrow pointing right
Actylis, NCS South Africa, and Agni Chemicals Announce Tripartite Partnership to Revolutionize Coating Resins in North America
February 1, 2024

Actylis, NCS South Africa, and Agni Chemicals Announce Tripartite Partnership

Actylis, NCS South Africa, and Agni Chemicals Announce Tripartite Partnership

Actylis has joined forces with NCS, a prominent South African polymer manufacturer with over 100 years in the paint and coatings industry, and Agni Chemicals, a creative entrepreneurial chemical supply chain company, to provide coating resins in North America from a new and reliable source outside of the APAC region.

See More Arrow pointing right
Actylis launches a New cGMP WFI Generation, Storage, and Distribution System with Additional ISO Class 7 Manufacturing Space as Part of its Continued Commitment to Supporting Biopharmaceutical Manufacturing
September 21, 2023

Actylis Expands WFI Manufacturing Capabilities in Canada

Actylis launched Water for Injection (WFI) and additional ISO Class 7 manufacturing space in Canada

Actylis today announced the launch of Water for Injection (WFI) and additional ISO Class 7 manufacturing space at its Baie d’Urfé site in Montreal, Canada. Used for the preparation of media, buffers, and other aqueous solutions, Actylis’ WFI meets monographs for pharmacopoeias worldwide, and can be provided in both custom and standard packaging configurations.

See More Arrow pointing right
Actylis Opens A 30,000ft2 cGMP Facility to Bolster its Innovative API Manufacturing Capabilities
February 27, 2023

Actylis opens innovative API manufacturing cGMP facility in Oregon, USA

Actylis opens a 30,000ft2 cGMP facility in Eugene, OR, USA to bolster our innovative API manufacturing capabilities.

The new facility focuses on the manufacture of innovative APIs and excipients at both clinical trial and full commercial scale. Our new state-of-the-art facility has 7 manufacturing suites and our clean rooms will be ISO Class 8 compliant by Q3. We have a number of different reactors to allow flexibility for a variety of chemistries.

See More Arrow pointing right